127 related articles for article (PubMed ID: 36744870)
21. Stratifying Risk of Future Growth Among Sporadic Vestibular Schwannomas.
Marinelli JP; Schnurman Z; Killeen DE; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland JT; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
Otol Neurotol; 2023 Aug; 44(7):e519-e524. PubMed ID: 37367632
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Behavior of Asymptomatic Incidental Vestibular Schwannomas Is Similar to That of Symptomatic Tumors.
Carlson ML; Lees KA; Patel NS; Lohse CM; Neff BA; Link MJ; Driscoll CL
Otol Neurotol; 2016 Oct; 37(9):1435-41. PubMed ID: 27576094
[TBL] [Abstract][Full Text] [Related]
23. The Association of Vestibular Schwannoma Volume With Facial Nerve Outcomes After Surgical Resection.
Killeen DE; Barnett SL; Mickey BE; Hunter JB; Isaacson B; Kutz JW
Laryngoscope; 2021 Apr; 131(4):E1328-E1334. PubMed ID: 33006401
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study.
Carlson ML; Tveiten ØV; Driscoll CL; Boes CJ; Sullan MJ; Goplen FK; Lund-Johansen M; Link MJ
J Neurosurg; 2015 Nov; 123(5):1276-86. PubMed ID: 26090830
[TBL] [Abstract][Full Text] [Related]
25. Correlation Between Aspirin Intake and Reduced Growth of Human Vestibular Schwannoma: Volumetric Analysis.
Kandathil CK; Cunnane ME; McKenna MJ; Curtin HD; Stankovic KM
Otol Neurotol; 2016 Oct; 37(9):1428-34. PubMed ID: 27631829
[TBL] [Abstract][Full Text] [Related]
26. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls.
Carlson ML; Tveiten OV; Driscoll CL; Goplen FK; Neff BA; Pollock BE; Tombers NM; Castner ML; Finnkirk MK; Myrseth E; Pedersen PH; Lund-Johansen M; Link MJ
J Neurosurg; 2015 Apr; 122(4):833-42. PubMed ID: 25555165
[TBL] [Abstract][Full Text] [Related]
27. Patient Demographics Influencing Vestibular Schwannoma Size and Initial Management Plans.
Ostler B; Killeen DE; Reisch J; Barnett S; Kutz JW; Isaacson B; Hunter JB
World Neurosurg; 2020 Apr; 136():e440-e446. PubMed ID: 31931234
[TBL] [Abstract][Full Text] [Related]
28. Volumetric analysis of tumor control following subtotal and near-total resection of vestibular schwannoma.
Jacob JT; Carlson ML; Driscoll CL; Link MJ
Laryngoscope; 2016 Aug; 126(8):1877-82. PubMed ID: 27426941
[TBL] [Abstract][Full Text] [Related]
29. Delayed Tumor Growth in Vestibular Schwannoma: An Argument for Lifelong Surveillance.
Macielak RJ; Patel NS; Lees KA; Lohse CM; Marinelli JP; Link MJ; Carlson ML
Otol Neurotol; 2019 Oct; 40(9):1224-1229. PubMed ID: 31469794
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Differences in Intracranial Facial Versus Vestibular Schwannomas: A Four Nerve Assessment.
Erbele ID; Klumpp ML; Arriaga MA
Laryngoscope; 2021 Sep; 131(9):2098-2105. PubMed ID: 34013983
[TBL] [Abstract][Full Text] [Related]
31. Preoperative diffusion tensor imaging-fiber tracking for facial nerve identification in vestibular schwannoma: a systematic review on its evolution and current status with a pooled data analysis of surgical concordance rates.
Savardekar AR; Patra DP; Thakur JD; Narayan V; Mohammed N; Bollam P; Nanda A
Neurosurg Focus; 2018 Mar; 44(3):E5. PubMed ID: 29490547
[TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis.
Su Z; Guo J; Gu Y
Clin Appl Thromb Hemost; 2022; 28():10760296221120423. PubMed ID: 36083182
[TBL] [Abstract][Full Text] [Related]
33. Conservative management of vestibular schwannoma: Predictors of growth and hearing.
Jethanamest D; Rivera AM; Ji H; Chokkalingam V; Telischi FF; Angeli SI
Laryngoscope; 2015 Sep; 125(9):2163-8. PubMed ID: 25647714
[TBL] [Abstract][Full Text] [Related]
34. Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model.
Manickavel S; Hartman Y; Burns A; Lora Gonzalez MA; Warram J; Walsh E; Hunter JB; Killeen DE
Otol Neurotol; 2023 Oct; 44(9):941-948. PubMed ID: 37641199
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma.
Marston AP; Jacob JT; Carlson ML; Pollock BE; Driscoll CLW; Link MJ
J Neurosurg; 2017 Aug; 127(2):380-387. PubMed ID: 27885952
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging surveillance following vestibular schwannoma resection.
Carlson ML; Van Abel KM; Driscoll CL; Neff BA; Beatty CW; Lane JI; Castner ML; Lohse CM; Link MJ
Laryngoscope; 2012 Feb; 122(2):378-88. PubMed ID: 22252688
[TBL] [Abstract][Full Text] [Related]
37. Growing versus non-growing vestibular schwannomas: assessment of natural history.
Dardis A; Donghun K; Kontorinis G
J Laryngol Otol; 2022 Oct; 136(10):934-938. PubMed ID: 34593068
[TBL] [Abstract][Full Text] [Related]
38. Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo.
Kandathil CK; Dilwali S; Wu CC; Ibrahimov M; McKenna MJ; Lee H; Stankovic KM
Otol Neurotol; 2014 Feb; 35(2):353-7. PubMed ID: 24448296
[TBL] [Abstract][Full Text] [Related]
39. Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality - An umbrella review.
Nowicka Z; Matyjek A; Płoszka K; Łaszczych M; Fendler W
Pancreatology; 2023 Mar; 23(2):192-200. PubMed ID: 36697348
[TBL] [Abstract][Full Text] [Related]
40. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E32-E34. PubMed ID: 29309686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
